Compare FBIN & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBIN | BLLN |
|---|---|---|
| Founded | 1988 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.6B |
| IPO Year | 2011 | 2025 |
| Metric | FBIN | BLLN |
|---|---|---|
| Price | $47.98 | $97.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 8 |
| Target Price | $49.06 | ★ $128.29 |
| AVG Volume (30 Days) | ★ 2.8M | 575.5K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | N/A | ★ 103.40 |
| EPS | 0.43 | ★ 0.81 |
| Revenue | ★ $4,463,200,000.00 | $305,112,000.00 |
| Revenue This Year | N/A | $51.61 |
| Revenue Next Year | N/A | $24.03 |
| P/E Ratio | ★ $111.02 | $118.64 |
| Revenue Growth | N/A | ★ 99.97 |
| 52 Week Low | $32.34 | $61.96 |
| 52 Week High | $64.84 | $150.44 |
| Indicator | FBIN | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 59.92 | 35.49 |
| Support Level | $36.96 | $89.26 |
| Resistance Level | $53.86 | $97.18 |
| Average True Range (ATR) | 2.17 | 6.32 |
| MACD | -0.01 | -1.89 |
| Stochastic Oscillator | 55.43 | 10.27 |
Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.